0001237899-21-000017.txt : 20210824 0001237899-21-000017.hdr.sgml : 20210824 20210824160445 ACCESSION NUMBER: 0001237899-21-000017 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210820 FILED AS OF DATE: 20210824 DATE AS OF CHANGE: 20210824 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fenimore Christopher R. CENTRAL INDEX KEY: 0001697422 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19034 FILM NUMBER: 211202250 MAIL ADDRESS: STREET 1: REGENERON PHARMACEUTICALS, INC. STREET 2: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERON PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0000872589 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133444607 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 BUSINESS PHONE: 9148477000 MAIL ADDRESS: STREET 1: 777 OLD SAW MILL RIVER ROAD CITY: TARRYTOWN STATE: NY ZIP: 10591 FORMER COMPANY: FORMER CONFORMED NAME: REGENERON PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930328 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2021-08-20 0 0000872589 REGENERON PHARMACEUTICALS, INC. REGN 0001697422 Fenimore Christopher R. 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 0 1 0 0 SVP Controller Common Stock 2021-08-20 4 M 0 13500 179.13 A 32520 D Common Stock 2021-08-23 4 S 0 4576 655.0 D 27944 D Common Stock 2021-08-23 4 S 0 9 659.33 D 27935 D Common Stock 2021-08-23 4 S 0 23 660.33 D 27912 D Common Stock 2021-08-23 4 S 0 88 661.89 D 27824 D Common Stock 2021-08-23 4 S 0 1 662.78 D 27823 D Common Stock 2021-08-23 4 S 0 70 663.05 D 27753 D Common Stock 2021-08-23 4 S 0 14 665.21 D 27739 D Common Stock 2082 I 2021 GRAT Common Stock 1459 I By 401(k) Plan Common Stock 1897 I By Trust Common Stock 1861 I by 2018 GRAT Common Stock 25 I by Trust for Daugh Common Stock 25 I by Trust for Son Non-Qualified Stock Option (right to buy) 179.13 2021-08-20 4 M 0 13500 0.0 D 2022-12-14 Common Stock 13500 0 D Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c). Represents volume-weighted average price of sales of 9 shares of Company stock on August 23, 2021 at prices ranging from $659.28 to $659.45. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price. Represents volume-weighted average price of sales of 23 shares of Company stock on August 23, 2021 at prices ranging from $660.09 to $660.88. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price. Represents volume-weighted average price of sales of 88 shares of Company stock on August 23, 2021 at prices ranging from $661.47 to $661.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price. Represents volume-weighted average price of sales of 70 shares of Company stock on August 23, 2021 at prices ranging from $663.00 to $663.13. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 23, 2021 at each separate price. These shares are held in a trust for the benefit of the reporting person's spouse. The reporting person and the reporting person's spouse are trustees of the trust. The stock option award vests in four equal annual installments, commencing one year after the date of grant. /s/**Christopher R. Fenimore 2021-08-23